Hawkins, Inc. $HWKN Shares Bought by Thrivent Financial for Lutherans

Thrivent Financial for Lutherans boosted its holdings in shares of Hawkins, Inc. (NASDAQ:HWKNFree Report) by 28.2% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 72,396 shares of the specialty chemicals company’s stock after purchasing an additional 15,931 shares during the quarter. Thrivent Financial for Lutherans owned approximately 0.35% of Hawkins worth $10,315,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Geode Capital Management LLC raised its stake in shares of Hawkins by 1.1% during the 2nd quarter. Geode Capital Management LLC now owns 478,348 shares of the specialty chemicals company’s stock worth $67,981,000 after buying an additional 5,110 shares during the period. Vaughan Nelson Investment Management L.P. raised its position in Hawkins by 35.1% during the second quarter. Vaughan Nelson Investment Management L.P. now owns 473,752 shares of the specialty chemicals company’s stock worth $67,320,000 after acquiring an additional 123,030 shares during the period. Invesco Ltd. raised its position in Hawkins by 50.3% during the second quarter. Invesco Ltd. now owns 282,349 shares of the specialty chemicals company’s stock worth $40,122,000 after acquiring an additional 94,503 shares during the period. Schroder Investment Management Group lifted its holdings in Hawkins by 130.7% during the second quarter. Schroder Investment Management Group now owns 149,397 shares of the specialty chemicals company’s stock valued at $21,229,000 after purchasing an additional 84,651 shares in the last quarter. Finally, Bank of New York Mellon Corp grew its position in shares of Hawkins by 0.4% in the second quarter. Bank of New York Mellon Corp now owns 148,173 shares of the specialty chemicals company’s stock valued at $21,055,000 after purchasing an additional 558 shares during the period. 69.71% of the stock is currently owned by hedge funds and other institutional investors.

Hawkins Trading Down 0.3%

HWKN opened at $142.57 on Thursday. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.43 and a quick ratio of 1.49. The company’s 50 day simple moving average is $143.21 and its two-hundred day simple moving average is $154.81. Hawkins, Inc. has a 1-year low of $98.30 and a 1-year high of $186.15. The firm has a market capitalization of $2.98 billion, a price-to-earnings ratio of 35.82, a price-to-earnings-growth ratio of 2.21 and a beta of 0.86.

Hawkins (NASDAQ:HWKNGet Free Report) last posted its quarterly earnings results on Wednesday, October 29th. The specialty chemicals company reported $1.08 EPS for the quarter, missing the consensus estimate of $1.24 by ($0.16). Hawkins had a net margin of 7.95% and a return on equity of 17.42%. The company had revenue of $280.43 million during the quarter, compared to analyst estimates of $284.42 million. Analysts expect that Hawkins, Inc. will post 4 EPS for the current fiscal year.

Hawkins Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, November 28th. Stockholders of record on Friday, November 14th were issued a dividend of $0.19 per share. This represents a $0.76 annualized dividend and a dividend yield of 0.5%. The ex-dividend date was Friday, November 14th. Hawkins’s payout ratio is currently 19.10%.

Insider Buying and Selling at Hawkins

In other news, VP Drew M. Grahek purchased 1,587 shares of the stock in a transaction dated Monday, November 3rd. The shares were purchased at an average price of $126.34 per share, with a total value of $200,501.58. Following the transaction, the vice president owned 39,640 shares in the company, valued at $5,008,117.60. The trade was a 4.17% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 4.10% of the company’s stock.

Analyst Ratings Changes

Several research analysts recently weighed in on HWKN shares. Zacks Research downgraded shares of Hawkins from a “hold” rating to a “strong sell” rating in a research report on Tuesday, November 4th. BWS Financial reissued a “buy” rating and set a $200.00 target price on shares of Hawkins in a report on Monday, November 3rd. Finally, Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Hawkins in a research note on Monday. Three research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $162.50.

Get Our Latest Stock Report on Hawkins

Hawkins Company Profile

(Free Report)

Hawkins, Inc operates as a specialty chemical and ingredients company in the United States. It operates through three segments: Industrial, Water Treatment, and Health and Nutrition. The Industrial segment offers industrial chemicals, products, and services to agriculture, chemical processing, electronics, energy, food, pharmaceutical, and plating industries.

Recommended Stories

Institutional Ownership by Quarter for Hawkins (NASDAQ:HWKN)

Receive News & Ratings for Hawkins Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hawkins and related companies with MarketBeat.com's FREE daily email newsletter.